3-7-24 FDN Impact report 23 Accessible - Flipbook - Page 8
Financial Report
2023 Revenue Sources
2023 Uses of Funds
APAF Corporate Alliance
ACADIA
Pharmaceuticals
Inc
Boehringer
Ingelheim
Indivior Inc.
Lundbeck
Pharmaceuticals
LLC
Sunovion
Pharmaceuticals
Inc.
Alkermes, Inc.
Cerevel
Therapeutics
Intra-Cellular
Therapies, Inc.
Myriad
Neuroscience
Supernus
Pharmaceuticals,
Inc.
Avanir
Pharmaceuticals
Compass
Pathways
Janssen
Pharmaceuticals, Inc.
Neurocrine
Biosciences, Inc.
Takeda
Pharmaceuticals
U.S.A., Inc.
Axsome
Therapeutics Inc.
Eisai, Inc.
Jazz
Pharmaceuticals
Otsuka America
Pharmaceutical, Inc
Bausch
Health
Greenwich
Biosciences
Karuna
Therapeutics
Sage Therapeutics,
Inc./ Biogen
THANK YOU!
Our work is made possible by generous individuals, foundations, and corporate partners like you.
We are grateful and could not have accomplished our goals and had the impact without your
support. To see a full list of our 2023 donors, please visit apafdn.org/ways-to-give/honor-roll
For more information or to make your 2024 gift, please visit
apafdn.org or TEXT APAF2024 to #44321
